Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin‐binding domain allows for affinity purification and in vivo half‐life extension

Publisher: John Wiley & Sons Inc

E-ISSN: 1860-7314|9|9|1215-1222

ISSN: 1860-6768

Source: BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol.9, Iss.9, 2014-09, pp. : 1215-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content